|
Friday, November 16, 2018
Print Current Session:
 |
|
|
Friday
SESSION 74:
MORE CAROTID TOPICS RELATED TO TIMING OF TREATMENT, MEDICAL TREATMENTS AND FUTURE CAS OPTIMISM
|
|
| SESSION 74 SCHEDULE | |
| OPTIMAL TIMING FOR TREATMENT – SOME DIFFERENT OPINIONS | |
| 10:52 AM - 10:57 AM | Optimal Timing Of CEA Or CAS After A Stroke Or TIA |
|
Presenter(s):Ross Naylor, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 10:58 AM - 11:03 AM | DEBATE: Why The Optimal Timing For CEA In Patients Who Have Had A TIA Or Minor Stroke Is 8-15 Days After The Event |
|
Presenter(s):Mark Conrad, MD, MMSc Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:04 AM - 11:09 AM | DEBATE: CEA From 2-5 Days After Onset Of The Index Neuro Symptom Has No Increased Risk But CEA <48 Hours After Symptom Onset Has Increased Risk: From The VSGNE |
|
Presenter(s):Mohammad H. Eslami, MD, MPH / Alik Farber, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:10 AM - 11:15 AM | Carotid Interventions After Ischemic Strokes Should Be Delayed 6-8 Weeks Only If The Cerebral Lesion Is Large (>4000 mm3) On CT |
|
Presenter(s):Gianluca Faggioli, MD / Andrea Stella, MD / Mauro Gargiulo, Professor Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:16 AM - 11:21 AM | DEBATE: CAS Is Justified Soon After Neurologic Symptoms If Certain Precautions Are Taken: How Soon: What Precautions |
|
Presenter(s):Carlo Setacci, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:22 AM - 11:27 AM | DEBATE: Early CAS From 2-7 Days After Neurologic Symptom Onset Has Increased Risk: CEA From 2-7 Days After Symptom Onset Has No Increased Risk: When Safe; When Not |
|
Presenter(s):Hans-Henning Eckstein, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:28 AM - 11:33 AM | Urgent Carotid Intervention In Patients With Mild To Moderate Strokes Is Associated With Improved Functional Independence On Discharge: How Long After A Stroke Should A Patient Undergo CEA: How About For CAS |
|
Presenter(s):Hernan A. Bazan, MD, FACS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| MEDICAL ISSUES | |
| 11:34 AM - 11:39 AM | In Patients With Carotid Disease Or A Stroke, What Level Of BP Maintenance Is Too Low: A Note Of Caution: What About LDL-C: Where Should It Be And Can It Be Too Low |
|
Presenter(s):J. David Spence, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:40 AM - 11:45 AM | The Currently Widely Used Antiplatelet Regimens For CAS Patients Are Not The Right Ones: How Should They Be Changed |
|
Presenter(s):Christos D. Liapis, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:46 AM - 11:51 AM | What Is On The Horizon For Improving CAS Outcomes: A Vascular Surgeon’s Epiphany: How TCAR, CREST 2 And New Stents Will Change The Game |
|
Presenter(s):Wesley S. Moore, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 11:52 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 74 | |
| previous | next |